作者
PJ Trivedi, GM Hirschfield
发表日期
2012/9
来源
Alimentary pharmacology & therapeutics
卷号
36
期号
6
页码范围
517-533
简介
Background
Autoimmune hepatitis (AIH), primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) all nestle within the family of autoimmune liver diseases, whereby the result of immune‐mediated liver injury gives rise to varied clinical presentations. Some patients demonstrate a phenotype whereby there is evidence of either PBC or PSC together with overlapping features of AIH. Due to an absence of well‐validated diagnostic criteria and a lack of large therapeutic trials, treatment of overlap conditions is empiric and extrapolated from data derived from the primary autoimmune liver diseases.
Aims
To review overlaps in the context of autoimmune liver diseases.
Methods
General and specific review of published articles using PubMed, Medline and Ovid search engines, alongside pre‐existing clinical management protocols, guidelines, and the authors' own knowledge of the published literature …
引用总数
20132014201520162017201820192020202120222023202416121914221112199931
学术搜索中的文章
PJ Trivedi, GM Hirschfield - Alimentary pharmacology & therapeutics, 2012